A Phase II Randomized Study Evaluating the Biological and Clinical ...

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in ...

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post ...

A Phase II Randomized Study Evaluating the Biological and Clinical ...

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant ...

ALICE: a randomized placebo-controlled phase II study evaluating ...

Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway. [email protected]. 2 Department of Cancer Immunology, Oslo ...

Randomized, Open-Label Phase II Study Evaluating the ... - PubMed

... evaluate addition of an oncolytic virus to a checkpoint inhibitor. Methods Patient … ... Clinical Trial, Phase II; Multicenter Study; Randomized ...

Phase 2, randomized, double-blind, placebo-controlled multi-center ...

Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients ...

A phase 2, randomized study of SB‐485232, rhIL‐18, in patients ...

Based on these preclinical and phase 1 clinical results, this phase 2 study was designed to evaluate the antitumor activity of 3 dose groups of ...

CLINICAL TRIAL PROTOCOL A Phase II, Randomized, Double ...

CLINICAL TRIAL PROTOCOL. A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TJ301 (FE ...

Phase I/II Randomized Trial Evaluating the Safety and Clinical ...

Abstract. Purpose: To evaluate the safety of repifermin (keratinocyte growth factor-2) administered before and after autologous hematopoietic stem cell.

An Overview of Phase 2 Clinical Trial Designs

... randomized phase 3 trial, as well as to further assess safety. These ... biological dose is established to assess toxicity further and ...

Phase II trials - memoinOncology

Phase II studies provide initial assessment of efficacy in a more homogeneous patient population. ... In clinical practice, single-arm versus randomized studies ...

Phase II randomized window of opportunity trial evaluating cytotoxic ...

... trial for intratumoral (IT) INT230-6 (comprising VINblastine (VIN) Cisplatin (VIN)) evaluating clinical and BioLogical Effects in patients with early-stage ...

Trial Phases 1, 2 & 3 Defined | Clinical Research Management (CRM)

Most Phase II studies are randomized, which means that subjects are assigned randomly (by chance not by choice) to receive either the experimental drug, a ...

A phase 2b, randomized, double-blind, placebo-controlled, clinical ...

In the Validation Study of the Oxford Classification of IgAN (VALIGA) study, which evaluated a broad European population with IgAN, there was a clear risk of ...

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 ...

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two ... JTO Clinical and Research Reports, 2(8), Article 100208. https ...

Paper: A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled ...

Research, clinical trials, Sickle Cell Disease, Clinical Research, Hemoglobinopathies, hematopoiesis, Diseases, Biological Processes.

Randomized, Placebo-Controlled, Phase II Trial of Intravenous ...

We conducted a phase II randomized clinical trial to determine whether intravenous infusion of banked, non-HLA matched unrelated donor umbilical cord blood ( ...

A randomized, double-blind, phase 2b proof-of-concept clinical trial ...

This was the first randomized phase 2 clinical trial evaluating ... Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical ...

We tested this in a randomized phase II signal-seeking study within the ATLANTIS clinical trial platform. ... Disease evaluation was via cross-sectional ...

An Overview of Phase 2 Clinical Trial Designs - ScienceDirect

... randomized phase 3 trial, as well as to further assess safety. These studies ... biological dose is established to assess toxicity further and obtain ...